Scientists test drug mix for lung disease
NCT ID NCT06241560
Summary
This study aims to understand how a common IPF medication, pirfenidone, affects the levels of a newer drug, BI 1015550, in the bloodstream. It involves about 20 adults with idiopathic pulmonary fibrosis (IPF) who will take both drugs according to a specific schedule. Researchers will measure drug levels in the blood to see if one changes how the body processes the other.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
LTD "Aversi clinic"
RECRUITINGTbilisi, 160, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LTD The First Medical Center
NOT_YET_RECRUITINGTbilisi, 0180, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Renovatio Clinical-The Woodlands-69551
NOT_YET_RECRUITINGThe Woodlands, Texas, 77380, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.